Clonevax SRL
Ouverture de failliteThe score of Clonevax shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +13 % Total assets +8 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Clonevax's annual accounts
Filed annual accounts
- Year ended 30 Sep 2024filed on 30 Apr 2025
- Year ended 30 Sep 2023filed on 24 May 2024
- Year ended 30 Sep 2022filed on 17 May 2023
- Year ended 30 Sep 2021filed on 14 Mar 2022
- Year ended 30 Sep 2020filed on 28 May 2021
Clonevax's financial analysis
- Solvency86.8%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Clonevax
Clonevax's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0874.375.915
- VAT number
- BE0874375915
- Peppol
- Registered · 0208:0874375915 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 May 2005
- Registered office
- 9800 Deinze
- Latest accounts
- 2024 · filed on 30 Apr 2025
- Activity
- Business and other management consultancy activities (NACE 70200)
Clonevax (SRL) has been based in Deinze since 2005, active in: business and other management consultancy activities. For 2024, it reports a net profit of 16,271 € and equity of 326,944 €; its revenue is not published. Its solvency stands at 86.8%, above the median of its sector (58.4%).
Companies similar to Clonevax
Companies in the same business, of comparable size and area, outside its group.
- Solutions In Projects Ruttens Business and other management consultancy activities Pelt · balance sheet 389,627 €
- Djuman Business and other management consultancy activities Charleroi · balance sheet 397,919 €
- Coresi Business and other management consultancy activities Mouscron · balance sheet 398,537 €
- Lakoco Business and other management consultancy activities Woluwe-Saint-Pierre · balance sheet 318,635 €
- Benson Group Business and other management consultancy activities Brussels · balance sheet 302,493 €
- GAJ-Services Business and other management consultancy activities Buggenhout · balance sheet 482,859 €
- Adilea Business and other management consultancy activities Etterbeek · balance sheet 495,602 €
- Toubkal Business and other management consultancy activities Meise · balance sheet 426,266 €
Frequently asked questions about Clonevax
What is the revenue of Clonevax?
Clonevax files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Clonevax?
In Belgium, the VAT number is the company number prefixed with BE: BE0874375915 for Clonevax, if the company is VAT-registered. Its company number (CBE) is 0874.375.915.
Where is the registered office of Clonevax?
According to the CBE register, the registered office of Clonevax is in 9800 Deinze.
What is the equity of Clonevax?
At the close of the 2024 financial year, the equity of Clonevax amounts to 326,944 €, a solvency of 86.8% of total assets.
Who manages Clonevax?
The register lists 2 active mandates at Clonevax. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Clonevax
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →